Evidence map›Paper›PMID 37667042›Full record

ArticleScientific reports2023

Optimized type-2 fuzzy controller based on IoMT for stabilizing the glucose level in type-1 diabetic patients.

Amged Sayed, Belal A Zalam, Mohanad Elhoushy, Essam Nabil

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Amged SayedDepartment of Industrial Electronics and Control Engineering, Faculty of Electronic Engineering, Menoufia University, Menouf, 32952, Egypt. eng_amged@yahoo.com.
Belal A ZalamDepartment of Industrial Electronics and Control Engineering, Faculty of Electronic Engineering, Menoufia University, Menouf, 32952, Egypt.
Mohanad ElhoushyDepartment of Industrial Electronics and Control Engineering, Faculty of Electronic Engineering, Menoufia University, Menouf, 32952, Egypt.
Essam NabilDepartment of Industrial Electronics and Control Engineering, Faculty of Electronic Engineering, Menoufia University, Menouf, 32952, Egypt.
Menoufia University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to advancements in existing Internet of Medical Things (IoMT) systems and devices, the blood glucose level (BGL) for type-1 diabetic patients (T1DPs) is effectively and continually monitored and controlled by Artificial Pancreas. Because the regulation of BGL is a very complex process, many efforts have been conducted to design a powerful and effective controller for the exogenous insulin infusion system. The main objective of this study is to propose an optimized interval type-2 fuzzy (IT2F) based controller of artificial pancreas for regulation BGL of T1DP based on IoMT. The proposed controller should avoid the risk of hyperglycemia and hypoglycemia situations that T1DP faces during the infusion of exogenous insulin. The main contribution of this work is using meta-heuristic method called grey wolf optimizer (GWO) to tune the footprint of uncertainty for IT2F's membership functions to inject the proper dose of insulin under different conditions. The nonlinear extended Bergman minimal model (EBMM) with uncertainty is used to represent the blood glucose regulation and represent the dynamics of meal disturbance in T1DP. The effectiveness and the performance of the proposed controller are investigated using MATLAB/Simulink platform. Simulation results show that the proposed controller can avoid both severe hypoglycemia and hyperglycemia for nominal parameters of the model, in addition to model under the presence of both parametric uncertainty and uncertain meal disturbance.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2HyperglycemiaHypoglycemiaBlood GlucoseHumansInsulinBlood GlucoseInsulin

Identifiers

PMID37667042
PMCPMC10477210
OpenAlexW4386422261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.